Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4135 Phomoxanthone A Natural anti-tumor agent, showing strong apoptotic anticancer effects against platinum-resistant solid cancers
DCC4136 Phosphatidylinositol Potent antagonist of (H1N1)pdm09 infection, markedly suppressing cytopathic effects and attenuating viral gene expression in (H1N1)pdm09-infected MDCK cells
DCC4137 phospho-sulindac Sulindac derivative with promising anticancer activities
DCC4138 Phosphotyrosine Inducer of platelet aggregation, playing a role in cellular signal transduction and possibly in cell growth control and carcinogenesis
DCC4139 Photac-i-3 Novel photoswitchable BET bromodomain Degrader (PHOTAC)
DCC4140 Photoazolol-1 Novel potent photoswitchable antagonist for a precise spatiotemporal control of β2-adrenoceptors
DCC4141 Photogbi1 Novel photocontrol inhibitor of the voltage-gated proton channel Hv1
DCC4142 Photo-lenalidomide-acid Functionalized photoswitchable cereblon ligand for Degraders
DCC4143 Photos1p Novel photoswitchable sphingolipid probe, reversibly controlled S1P3-dependent pain hypersensitivity in mice and uniquely suited for the study of S1P biology in cultured cells and in vivo
DCC4144 Photosensitizer Pz I Novel porphyrazine-based photodynamic anti-cancer agent, inducing immunogenic cell death
DCC4145 Photosensitizer Pz Iii Novel porphyrazine-based photodynamic anti-cancer agent, inducing immunogenic cell death
DCC4146 Photosph Novel photoswitchable sphingolipid probe
DCC4147 Phototrexate Novel photoswitchable inhibitor of human dihydrofolate reductase
DCC4148 Phyllospadine Natural flavonoidal alkaloid from the sea-grass Phyllosphadix iwatensis
DCC4149 Physapubenolide Natural cytotoxic withanolide antitumor agent, inducing apoptosis by decreasing mitochondrial membrane potential and elevating the Bax/Bcl-2 protein expression ratio
DCC4150 Physodic Acid Natural inhibitor of Wnt signaling, modulating β-catenin-dependent transcription
DCC4151 Pi-090 Platelet aggregation inhibitor
DCC4152 Pi-091 Platelet aggregation inhibitor
DCC4153 Pi-2620 Novel Tau ligand, displaying high Tau binding, low MAO-A binding, high brain uptake, and fast and complete brain washout
DCC4154 Pi3k/akt/mtor-in-6be Novel inhibitor of the PI3K/Akt/mTOR signaling pathways, activating P53 and inducing apoptosis
DCC4155 Pi3k/akt-in-c89 Novel Inhibitor of the PI3K-Akt Pathway, Inducing Autophagy of Female Germline Stem Cells
DCC4156 Pi3kd/v-in-01 Highly potent ATP-competitive PI3Kdelta/Vps34 dual inhibitor
DCC4157 Pi3ki1 Novel potent PI3K inhibitor with a modified omipalisib structure
DCC4158 Pi3k-in-s1 Novel PI3K inhibitor, synergizing with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
DCC4159 Piboserod Hydrochloride Selective 5-HT4 receptor antagonist
DCC4160 Picrasidine N Novel Subtype-Selective PPARbeta/delta Agonist
DCC4161 Picumeterol Potent and selective beta2-adrenoceptor agonist
DCC4162 Pikamilone Sodium Prodrug of GABA, used for treatment of neurogenic bladder in spinal and benign prostatic hyperplasia
DCC4163 Pik-c98 Novel PI3K inhibitor, displaying potent preclinical activity against multiple myeloma
DCC4164 Piloquinone Natural activator of cryptic biosynthetic gene clusters (BGC), also acting as a potent inhibitor of monoamine oxidase B

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X